Rebalancing cortical neuronal hyperactivity as a new treatment strategy in neuroinflammation

B09

In the previous funding period we discovered a maladaptive cortical network dysregulation linked with anxiety behavior as a pathological mechanism in murine neuroinflammation contributing to initiation of neurodegeneration. We now aim at (1) dissecting the causal relation between brainstem pathology and cortical maladaptive hyperactivity, (2) unravelling the relation of local network dysregulation to brain-wide networks, and (3) pharmacologically modulating cortical hyperexcitability and translating our findings to MS patients. These research questions will be investigated:

    1. Does the modulation of AMPA receptors have an effect in neuroinflammatory disorders?
    2. Does the reversal of anxiety symptoms prevent neurodegeneration?
    3. What’s the relation between local nework dysregulation in relapsing-remitting MS with brain-wide networks?
    4. Is there a causal relation between brainstem pathology and cortical maladaptive hyperactivity?

 

 

 

 

 

Principal Investigators:

Dr. med. Erik Ellwardt
Klinik für Neurologie
Mainz
erik.ellwardt@unimedizin-mainz.de

Prof. Dr. rer. nat. Albrecht Stroh
Institut für Mikroskopische Anatomie und Neurobiologie
Mainz
albrecht.stroh@unimedizin-mainz.de

News

Thu, 28/01/2021
BioNTech Publishes Data on Novel mRNA Vaccine Approach to Treat Autoimmune Diseases in Science
BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced the publication of preclinical data on its novel mRNA vaccine approach against autoimmune diseases in the peer-reviewed journal Science. The publication titled “A non-inflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis” co-authored by SFB principal investigator Ari Waisman summarizes the findings on the disease-suppressing effects […]...more
Wed, 20/01/2021
A new study on neurological manifestations of severe COVID-19 reveals nervous system immune deficiency
Patients suffering from COVID-19 can develop concomitant and long-term symptoms in their nervous system. The most common symptom in this context is the loss of the sense of smell and taste, while more severe symptoms such as stroke, cerebral seizures, or meningitis are possible. A team of scientists from the medical faculties at the Universities […]...more
Fri, 15/01/2021
Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity
It has long been acknowledged that multiple sclerosis disease risk is associated with reduced sun-exposure, and subsequent low vitamin D levels. The study by Ostkamp et al. now assessed the relationship between measures of sun exposure and MS severity. For this, the researchers analyzed data of around 2,000 patients from the German NationMS- and the […]...more